RecruitingType 2 Diabetes MellitusChronic Kidney Diseases
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Eligible age
30–80 yrs
Accepts
All genders
Locations
28 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Sponsor: Prokidney
Where it's recruiting
Alabama
Huntsville
Arizona
Tucson
California
Beverly Hills · Glendora · Granada Hills · Huntington Park …
Delaware
Newark
Florida
Coral Springs · Fort Lauderdale · Gainesville · Jacksonville …
Georgia
Acworth · Augusta
Idaho
Boise · Chubbuck
Illinois
Chicago
Indiana
Fishers · Mishawaka
Iowa
Iowa City
Kentucky
Lexington
Louisiana
Shreveport
Source: ClinicalTrials.gov · NCT05099770 · last updated 2026-03-23